Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06321471 · ClinicalTrials.gov registry record · NA

AeviceMD for Pediatric Asthma Management

A NA study of Asthma and Asthma in Children, sponsored by Irina Dralyuk.

Recruiting
Registry status
NA
Development phase
20
Enrollment target
1
Study location

NCT06321471 is a NA study of Asthma and Asthma in Children that is actively recruiting participants, run by Irina Dralyuk. The registered enrollment target is 20 participants, below the 1,563-participant average among 374 other Asthma trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06321471, a NA study of Asthma and Asthma in Children, is actively recruiting participants, sponsored by Irina Dralyuk.

RECRUITING
Registry status
NA
Development phase
20 participants
Enrollment target
1
Study location

Study Summary

A wearable remote patient monitor (AeviceMD) is to be used to monitor the respiratory health of pediatric asthma patients in this pilot study. Patients prescribed with AeviceMD should be able to gain better control over their disease during home management. Physicians should be able to optimize treatment for these patients using objective data collected from and of these patients outside of the clinic. The AeviceMD should also be used as a remote auscultation device for teleconsultations.

Interventions

  • DEVICE AeviceMD

Study Locations (1)

California

  • Cedars-Sinai Medical Center - Los Angeles

Trial Details

FieldValue
Enrollment Target 20 participants
Start Date 2024-11-05
Est. Completion 2026-02
Phase NA

Sponsor

Irina Dralyuk

1 total trials

What the Registry Record Tells You About NCT06321471

The ClinicalTrials.gov registry entry for NCT06321471 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,563-participant average among 374 other Asthma trials with a reported enrollment target (99% lower). The listed sponsor is Irina Dralyuk, which has 1 total studies on file at ClinicalTrials.gov.

The record links to 4 conditions, with Asthma appearing as the primary indexed condition, and to 1 intervention - of which AeviceMD is the first listed.

NCT06321471 reports 1 study location spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT06321471 about?

NCT06321471 is a clinical study titled "AeviceMD for Pediatric Asthma Management". A wearable remote patient monitor (AeviceMD) is to be used to monitor the respiratory health of pediatric asthma patients in this pilot study. Patients prescribed with AeviceMD should be able to gain better control over their disease during home management. Physicians should be able to optimize trea...

What is the current status of trial NCT06321471?

This trial is currently recruiting. It is a NA study. The enrollment target is 20 participants. The study started on 2024-11-05. Estimated completion is 2026-02.

What conditions does trial NCT06321471 study?

This clinical trial studies the following conditions: Asthma, Asthma in Children, Pediatric Asthma, Chronic Respiratory Disease.

What interventions are being tested in trial NCT06321471?

The interventions under investigation include: AeviceMD (DEVICE).

Who is sponsoring clinical trial NCT06321471?

This trial is sponsored by Irina Dralyuk, which has 1 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06321471 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Asthma

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.